Antibody drug conjugates
US11725024B2 · kind B2 · utility
2Cited by
20References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2022 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Apr 27, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y203/02013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibody drug conjugates comprising STING modulators. Also provided are compositions comprising the antibody drug conjugates. The compounds and compositions are useful for stimulating an immune response in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.